Overview

This is a follow-up study of a randomised clinical trial, called TEMPO (a double-blind randomized clinical trial investigating infant formula and human breast milk consumption), in which infants participated in their first year of life. The investigators like to know if these children develop allergies or infections in childhood and whether their feeding pattern in infancy plays a role.

Eligibility

Inclusion Criteria:

• Subjects are eligible to participate in the TEMPO Follow-Up study in case:
• they completed the final (12 months) visit in the TEMPO study.
• parents agree that their contact details will be shared with a third party for study purposes.
• parents agree that data collected in the TEMPO study will be used in the TEMPO Follow-Up study.
• parents provide written informed consent for participation in the TEMPO Follow-Up in accordance with local law.

Exclusion Criteria:

• Parents who do not have a smartphone, tablet or personal computer with internet access.